A-P method may calculate IOL power

Article

The anterior-posterior (A-P) method is effective for calculating IOL power when preoperative LASIK data is unavailable.

The anterior-posterior (A-P) method is effective for calculating IOL power when preoperative LASIK data is unavailable, states a paper in the Journal of Cataract and Refractive Surgery.

A retrospective case series led by Dr Megumi Saiki, Department of Ophthalmology, Keio University Hospital, Tokyo, Japan, included eyes undergoing phacoemulsification and IOL implantation after myopic LASIK.

The A-P method includes modifying the double-K method using the SRK/T formula. The accuracy of the A-P method was compared with other formulae that do not require preoperative data and formulae that do require preoperative data.

The median values of the arithmetic and absolute prediction errors with the A-P method were 0.16 D and 0.54 D, respectively. Prediction errors using the A-P method were within ±0.50 D in 46.4% of eyes and within ±1.00 D in 75.0%. Using the A-P method is a successful option for calculating IOL in eyes undergoing cataract surgery.

The abstract can be read here.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.